Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-025826
Filing Date
2025-08-11
Accepted
2025-08-11 09:16:04
Documents
59
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcda20250630_10q.htm   iXBRL 10-Q 788746
2 EXHIBIT 31.1 ex_848213.htm EX-31.1 10992
3 EXHIBIT 31.2 ex_848227.htm EX-31.2 11218
  Complete submission text file 0001437749-25-025826.txt   4029001

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bcda-20250630.xsd EX-101.SCH 42314
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20250630_def.xml EX-101.DEF 264903
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20250630_lab.xml EX-101.LAB 224655
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20250630_pre.xml EX-101.PRE 292170
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcda-20250630_cal.xml EX-101.CAL 26875
62 EXTRACTED XBRL INSTANCE DOCUMENT bcda20250630_10q_htm.xml XML 577735
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38999 | Film No.: 251200470
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)